Senores Pharma IPO allotment today: Check status, GMP, listing schedule

Q: How long will it take to read this news story?

The story "Senores Pharma IPO allotment today: Check status, GMP, listing schedule" has 452 words across 17 sentences, which will take approximately 2 - 4 minutes for the average person to read.

Q: Which news outlet covered this story?

The story "Senores Pharma IPO allotment today: Check status, GMP, listing schedule" was covered 15 hours ago by Business Standard, a news publisher based in India.

Q: How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news. The outlet is headquartered in India and publishes an average of 223 news stories per day. It's most recent story was published 3 hours ago.

Q: What do people currently think of this news story?

The sentiment for this story is currently Neutral, indicating that people are not responding positively or negatively to this news.

Q: How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.<ul><li>News ID: #24666655</li><li>URL: https://beamstart.com/news/senores-pharma-ipo-allotment-today-17351815973664</li></ul>

Business Standard Logo Business Standard 15h ago

Senores Pharma IPO allotment today: Check status, GMP, listing schedule - Business Standard

Quick Summary:

Unlisted shares of Senores Pharmaceuticals were trading at Rs 631 per share, reflecting a GMP of Rs 240 per share or 61.

As of September 30, 2024, the company has launched 55 products in key therapeutic areas, including antibiotics and antifungal treatments.

This was followed by Qualified Institutional Buyers (QIBs), who bid for 94.66 times their allocated quota, and Retail Individual Investors (RIIs), who subscribed to 90.46 times their quota.